| Name | Title | Contact Details |
|---|
Verde Science has assembled an impressive team of scientists from highly technical disciplines including Bioprocess Technology, Nanotechnology, Molecular Virology and Immunology, Molecular Biology, Pharmacology and Medical Device Design. Our focus is the discovery of novel drugs and new treatment modalities, as well as cutting edge diagnostic devices and pharmaceutical delivery systems for the treatment of emerging diseases and contemporary medical issues where current treatments either do not exist or are inadequate. Our Research and Development program includes collaboration with our R&D alliance partners which include the Sterkem Group, an integrated pharmaceutical firm based in Mumbai, India; the Institute for Chemical Technology, a Mumbai, India based science and technology university; and our researchers based in India and Canada. We believe that this synergistic and nimble team of highly skilled scientists is the most cost-effective and efficient way to rapidly respond to the increasing array of inadequately addressed contemporary medical issues facing the world community. An initial focus is on developing custom medicinal formulations from cannabinoids and THC compounds for the treatment of specific issues such as migraines, glaucoma, loss of appetite from cancer therapies, and numerous other medical issues. Verde also plans to alpha test innovative growing technologies in India as part of the company’s initiatives.
Energizing chemistry – news and stories from a leader in specialty chemicals.
American Bio Medica Corporation develops, manufactures, and sells immunoassay tests for the immediate point of collection testing (POCT) for drugs of abuse (DOA) in urine and oral fluids. It provides urine-based POCT products that comprise Rapid Drug Screen to detect the presence or absence of 2 to 10 DOA; Rapid ONE for testing the presence or absence of a single DOA; RDS InCup, which detects the presence or absence of 2 to 12 DOA; Rapid TOX that detects the presence or absence of 2 to 10 DOA; and Rapid TOX Cup II for detecting the presence or absence of 2 to 14 DOA. The company’s urine-based POCT products test various drugs, including amphetamines, barbiturates, benzodiazepines, buprenorphine, cocaine, MDMA, methadone, methamphetamines, opiates, oxycodone, phencyclidine, propoxyphene (PCP), marijuana (THC), and tricyclic antidepressants. It also offers oral fluid based POCT products comprising OralStat to detect DOA; and Rapid Status II that enhances drug recovery and provides a transport container for confirmation of positive test results. The company’s oral fluid based POCT products test amphetamines, barbiturates, benzodiazepines, cocaine, MDMA, methadone, methamphetamines, opiates, PCP, propoxyphene, and THC drugs. In addition, it distributes Rapid Reader, a compact portable unit that uses a camera to capture a picture of the results obtained when using an ABMC POCT product; and POCT products to detect the presence or absence of adulterants and alcohol. Further, the company offers bulk strip contract manufacturing services to various non-affiliated POCT diagnostic companies. It serves workplace, government, clinical, rehabilitation, and education markets directly, as well as through distributors in the United States and internationally. The company was formerly known as American Micro Media, Inc. and changed its name to American Bio Medica Corporation in September 1992. American Bio Medica Corporation was founded in 1986 and is based in Kinderhook, New York.
Lows Ready Mix Inc is a Eagle, ID-based company in the Manufacturing sector.
Adirondack Environmental is a Albany, NY-based company in the Manufacturing sector.